7+Years of programmes
MultiMedical disciplines
GlobalSpeaker network
TrustedBy academia & industry
From fundamental research to industrial translation — GSOD 2027 invites original contributions across the full breadth of obesity.
Incretin-based pharmacotherapy has redefined obesity medicine, with semaglutide 2.
ExploreBariatric and metabolic surgery remains the most durable intervention for class II–III obesity, with 10–20 year data from RYGB and sleeve gastrectomy demonstrating sustained weight loss, diabetes remission, and reduced all-cause mortality.
ExplorePediatric obesity affects nearly one in five US children and is now treated as a chronic disease in the 2023 AAP Clinical Practice Guideline, which endorses intensive health behavior and lifestyle treatment from age 6, pharmacotherapy from age 12, and surgery evaluation from age 13.
ExploreThe leptin–melanocortin pathway underpins both rare monogenic obesity and emerging precision therapies.
ExploreCardiovascular-Kidney-Metabolic (CKM) syndrome, formalized by the AHA in 2023, reframes obesity, insulin resistance, MASLD, CKD, and ASCVD as a single pathophysiologic continuum.
ExploreEven in the GLP-1 era, intensive lifestyle therapy remains foundational and amplifies pharmacologic and surgical outcomes.
ExploreGSOD 2027 is a global forum for pioneering research, clinical translation and cross-disciplinary dialogue across obesity, diabetes and weight management.
Across two days of keynotes, parallel technical tracks, poster sessions and applied workshops, we convene the brightest minds to chart the frontier of metabolic care.
GSOD 2027 is more than a conference — it is a launchpad for your research, your clinical practice, and your next translational collaboration.
Hear first on breakthrough findings across 35 scientific sessions in obesity.
Keynote, plenary and invited speakers from leading US and international institutions.
Connect with researchers, clinicians and industry leaders across 12+ countries — in one room, over two days.
All accepted abstracts published in the ISBN-allocated proceedings; selected papers invited to partner journals.
Best Paper, Best Poster and Young Investigator awards with global visibility and certificates of excellence.
Two days of curated networking and a gala dinner — attend on-site in the USA or stream every session live, worldwide.
Early-bird pricing available until July 14, 2026. All fees include the full two-day program, conference kit, lunches and networking events.
Mark these deadlines to stay ahead of abstract submission, registration and arrival.
Everything you need to submit abstracts, prepare presentations, and share GSOD 2027 with your colleagues.